GO
Loading...

Companies

More

  • May 1- Vertex Pharmaceuticals Inc on Thursday said a combination of its cystic fibrosis drug Kalydeco with an experimental compound was shown to improve lung function in a mid-stage trial, and its shares rose 10 percent after the news.

  • Jim Cramer: How these two incoming CEOs stack up Thursday, 1 May 2014 | 11:21 AM ET
    Mark Fields

    Two big succession stories dominated the headlines Thursday morning, and to CNBC's Jim Cramer, they couldn't be more different.

  • *Yelp shares up in premarket as revenue jumps. Health insurer Cigna Corp reported first-quarter earnings that beat expectations, while Cardinal Health's revenue was below forecasts, sending shares down 2.2 percent to $68 in premarket trading. *Late Wednesday, Yelp Inc reported a 66 percent rise in quarterly revenue.

  • *Yelp shares up in premarket as revenue jumps. Health insurer Cigna Corp reported first-quarter earnings that beat expectations, while Cardinal Health's revenue was below forecasts, sending shares down 2.2 percent to $68 in premarket trading. *Late Wednesday, Yelp Inc reported a 66 percent rise in quarterly revenue.

  • *Yelp shares up in premarket as revenue jumps. Health insurer Cigna Corp reported first-quarter earnings that beat expectations, following similarly positive results from competitors WellPoint Inc and Aetna Inc. Textron Inc's earnings fell from the prior year while revenue was nearly flat.

  • May 1- Merrimack Pharmaceuticals Inc said its lead experimental cancer drug when used as a combination improved the overall survival rate in patients with metastatic pancreatic cancer, doubling its shares in premarket trading.

  • Shares of RF Micro, whose customers include Apple Inc and Samsung Electronics Co, rose about 7.5 percent in extended trading after the chipmaker also posted a better-than-expected profit for the fourth quarter.

  • April 29- Pharmacy benefit manager Express Scripts Holding Co on Tuesday posted a lower-than-expected first-quarter profit and decreased its earnings forecast for full-year 2014, saying adjusted prescription volume would be less than it had anticipated. Express Scripts shares fell 6 percent in extended trading.

  • *Twitter to report earnings after market close. NEW YORK, April 29- U.S. stocks rose on Tuesday, boosted by upbeat results from companies including Merck& Co and a rebound in Facebook and other high-growth shares. Merck& Co' s shares climbed 3.6 percent to $58.72, giving the S&P 500 its biggest lift, after it reported stronger-than-expected earnings.

  • NEW YORK, April 29- U.S. stocks rose on Tuesday, boosted by upbeat earnings from companies including Merck& Co and a rebound in Facebook and other high-growth shares.

  • UPDATE 2-3D Systems gross margin slips, shares slide Tuesday, 29 Apr 2014 | 1:19 PM ET

    April 29- 3 D printer maker 3 D Systems Corp's quarterly gross margins fell for the first time in two years, raising concerns about its growth prospects in an industry, which is drawing the attention of bigger technology firms. 3 D Systems shares fell as much as 11 percent, making the stock one of the top losers on the New York Stock Exchange on Tuesday morning.

  • *Twitter to report earnings after market close. NEW YORK, April 29- U.S. stocks edged higher on Tuesday following better-than-expected earnings from Merck& Co and Sprint Corp.. The Dow Jones industrial average outperformed the broader market as component Merck& Co' s shares jumped nearly 3 percent to $58.31 after its earnings report.

  • Twitter to report earnings after market close. NEW YORK, April 29- U.S. stocks rose on Tuesday following better-than-expected earnings from Merck& Co and Sprint Corp.. The Dow Jones industrial average was outperforming the broader market as component Merck& Co' s shares jumped nearly 3 percent to $58.42 after its earnings report.

  • *Twitter to report earnings after the bell. *EU sanctions 15 politicians, military leaders over Ukraine. Britain's Reckitt Benckiser Group Plc also confirmed it was in talks to buy Merck& Co's consumer health business, the latest asset up for grabs in a wave of recent pharmaceutical deals.

  • China shares halt losing streak on solid earnings Tuesday, 29 Apr 2014 | 3:08 AM ET

    BEIJING, April 29- China's two main indexes broke four-day losing streaks on Tuesday, as a strong earnings report from insurance giant Ping An spurred solid gains. Ping An Insurance Group of China Co Ltd had a strong impact on both indexes after it reported a 46 percent rise in first-quarter profit, sending its shares up 2.6 percent.

  • Why we can survive in the iPad era: Lego CEO Monday, 28 Apr 2014 | 7:18 PM ET

    While it seems that kids are playing with touchscreens more than toys, Lego Group is confident that the building-blocks will remain relevant forever.

  • Does M&A activity suggest US tax code is broken? Monday, 28 Apr 2014 | 4:24 PM ET

    Pfizer's $100 billion offer to acquire British rival AstraZeneca is an effort to achieve an "efficient" tax structure, the company said.

  • NEW YORK, April 28- Shares of AstraZeneca surged on Monday after a takeover offer, lifting global equity markets on speculation of further corporate deal-making, while crude oil prices fell on increased U.S. sanctions against Russia over the Ukraine crisis.

  • MOSCOW, April 28- Shares in Russian oil company Rosneft and its major shareholder British BP fell on Monday after the United States announced sanctions against Rosneft's Chief Executive Igor Sechin over the Ukraine crisis.

  • Shares of the company, whose cruise lines include Royal Caribbean International, Celebrity Cruises and Azamara Club Cruise, fell as much as 3.2 percent in early trading. Royal Caribbean said its cruise operations were hurt by several mishaps in the first quarter. Royal Caribbean has also been struggling to boost sales in the Caribbean, its biggest market.